Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1997 4
1998 2
2000 1
2001 1
2002 1
2003 2
2004 1
2005 2
2006 2
2008 1
2009 1
2010 6
2011 3
2012 9
2013 1
2014 3
2015 1
2016 6
2017 3
2018 4
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all
Page 1
Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris.
Anderson KS, Petersson S, Wong J, Shubbar E, Lokko NN, Carlström M, Enerbäck C. Anderson KS, et al. Br J Dermatol. 2010 Nov;163(5):1085-9. doi: 10.1111/j.1365-2133.2010.09990.x. Br J Dermatol. 2010. PMID: 20716221
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
Hammerberg C, Arend WP, Fisher GJ, Chan LS, Berger AE, Haskill JS, Voorhees JJ, Cooper KD. Hammerberg C, et al. J Clin Invest. 1992 Aug;90(2):571-83. doi: 10.1172/JCI115896. J Clin Invest. 1992. PMID: 1386612 Free PMC article.
Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis.
Kristensen M, Deleuran B, Eedy DJ, Feldmann M, Breathnach SM, Brennan FM. Kristensen M, et al. Br J Dermatol. 1992 Oct;127(4):305-11. doi: 10.1111/j.1365-2133.1992.tb00446.x. Br J Dermatol. 1992. PMID: 1419749
Up-regulation of receptor antagonist interleukin-1 family members in psoriasis and their regulation by pro-inflammatory cytokines.
Kim HJ, Kim SH, Park J, Lee M, Kim DS, Lee MG. Kim HJ, et al. J Dermatol Sci. 2016 Jun;82(3):204-6. doi: 10.1016/j.jdermsci.2016.02.003. Epub 2016 Feb 12. J Dermatol Sci. 2016. PMID: 26917344 No abstract available.
An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases.
Pazyar N, Feily A, Yaghoobi R. Pazyar N, et al. Curr Clin Pharmacol. 2012 Nov;7(4):271-5. doi: 10.2174/157488412803305821. Curr Clin Pharmacol. 2012. PMID: 22794157 Review.
Lack of association of the IL-1RN and IL-10 polymorphisms with risk of psoriasis: A meta-analysis.
Qiao J, Jia QN, Jin HZ. Qiao J, et al. Mol Genet Genomic Med. 2019 Jan;7(1):e00512. doi: 10.1002/mgg3.512. Epub 2018 Dec 6. Mol Genet Genomic Med. 2019. PMID: 30523673 Free PMC article.
Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist.
Shepherd J, Little MC, Nicklin MJ. Shepherd J, et al. J Invest Dermatol. 2004 Mar;122(3):665-9. doi: 10.1111/j.0022-202X.2004.22305.x. J Invest Dermatol. 2004. PMID: 15086551 Free article.
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2.
Debets R, Timans JC, Homey B, Zurawski S, Sana TR, Lo S, Wagner J, Edwards G, Clifford T, Menon S, Bazan JF, Kastelein RA. Debets R, et al. J Immunol. 2001 Aug 1;167(3):1440-6. doi: 10.4049/jimmunol.167.3.1440. J Immunol. 2001. PMID: 11466363 Free article.
Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis.
Minkis K, Aksentijevich I, Goldbach-Mansky R, Magro C, Scott R, Davis JG, Sardana N, Herzog R. Minkis K, et al. Arch Dermatol. 2012 Jun;148(6):747-52. doi: 10.1001/archdermatol.2011.3208. Arch Dermatol. 2012. PMID: 22431714 Free PMC article.
IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis.
Hammerberg C, Bata-Csorgo Z, Voorhees JJ, Cooper KD. Hammerberg C, et al. Arch Dermatol Res. 1998 Jul;290(7):367-74. doi: 10.1007/s004030050319. Arch Dermatol Res. 1998. PMID: 9749991 Free article.
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page